The price-to-earnings ratio has its supporters and detractors, but this simple statistic can be an easy way for investors to gauge how cheap an average stock is on the fly. For some stocks, however, the P/E ratio is a misleading statistic -- particularly when earnings betray a poor business model. With stocks' rise this year and earnings on the upswing, however, is the P/E ratio a suitable fit in the medical device industry, particularly as many device stocks have soared in 2013?
Using data compiled by stock screening site Finviz.com, here are three of the cheapest medical device stocks in the industry as sorted by the P/E ratio. Are these picks worth your investment -- or is this simple statistic hiding lagging financials and flailing companies? Motley Fool contributor Dan Carroll tells you what you need to know about the device industry's cheapest pickings below.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of.�Click here now�to keep reading.
10 Best Defense Stocks To Watch For 2015: TASER International Inc.(TASR)
TASER International, Inc. develops, manufactures, and sells electronic control devices (ECD) for use in the law enforcement, military, corrections, private security, and personal defense markets. ECDs transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. Its products for the law enforcement, military, corrections, and professional security market include the TASER X26 product line, which consists of TASER X26, various cartridges, a digital power magazine, data download software and equipment, extended warranties, and a range of holstering options and accessories; TASER X3, a multi-shot ECD that would engage three separate targets; and ADVANCED TASER M26 product line comprising the ADVANCED TASER M26, various cartridges, rechargeable batteries, a battery charging system, data download software and equipment, extended warranties, and various holstering options and accessories. The company also provides TASER XREP, a self-contained, wireless ECD that deploys from a 12-gauge pump-action shotgun; and TASER Shockwave security system for safety and stand-off capability during hostile situations. In addition, it manufactures TASER C2, TASER X26C, and ADVANCED TASER M26C devices for the personal defense market, as well as provides various cartridges and other accessories. The company sells its products worldwide through its direct sales force, distribution partners, online store, and third-party resellers. TASER International, Inc. was founded in 1993 and is headquartered in Scottsdale, Arizona.
Advisors' Opinion:- [By Rich Smith]
In its latest update on stun-gun sales, TASER International (NASDAQ: TASR ) reported Thursday that it's booked several new orders for its eponymous stun guns.
- [By Ben Levisohn]
Taser International (TASR) has jumped 3.8% to $17.10 after beating earnings and revenue forecasts and reporting a larger profit margin.
Lakeland Industries (LAKE) have soared 49% to $16.08 after the company said it would double production to handle a rapid increase in orders for its hazmat suits used to protect against Ebola.
- [By James E. Brumley]
On the surface, the press release in and of itself may seem benign ... almost innocuous. When you start to proverbially put two and two together, however, this morning's news from View Systems Inc. (OTCBB:VSYM) could actually be early notice that things are about to change for the young, small company. By digging deeper into the details, it becomes clear that VSYM could become in Brazil what TASER International, Inc. (NASDAQ:TASR) and OSI Systems, Inc. (NASDAQ:OSIS) have become in the United States - security icons. View Systems shareholders could be on the same bullish receiving end of things that OSIS and TASR shareholders were on when each of those companies were experiencing a growth spurt a few years back.
- [By Lee Jackson]
TASER International Inc. (NASDAQ: TASR) is on a growth path, having reported double-digit revenue increases for eight quarters in a row. The company claims to produce “the world’s safest and most effective weapons” that are becoming popular with the U.S. police departments. TASER’s stun guns practically have no serious competition. J.P. Morgan has a $20 target, and the consensus target is $20.33. TASER closed Tuesday at $18.50.
Hot Cheapest Stocks For 2014: SeaChange International Inc.(SEAC)
SeaChange International, Inc. provides multi-screen video products and services that facilitate the aggregation, licensing, management, and distribution of video, television programming, and advertising content to cable system operators, telecommunications companies, broadcast television companies, and mobile communications providers worldwide. The company operates in two segments, Software and Media Services. The Software segment offers back-office products, including SeaChange Axiom, an on-demand back office software that allow operators to centralize video distribution systems, as well as video streamers; advertising product solutions, such as video-on-demand, digital video recorders, and over-the-top services; and home gateway product solutions, which include Nucleus, a hybrid gateway software product that provides control over channel changes, VOD/DVR playback, and trick mode set-top box functionalities. This segment also provides professional services, installation, training, project management, product maintenance, technical support, and software development related services. The Media Services segment offers content for video-on-demand and pay-per-view platforms; and marketing, promotional, and production services to cable operators and telecommunications providers. This segment also sources, acquires, packages, and markets video-on-demand services by providing access to content from local and Hollywood studio providers in various formats, including music videos, television programs, and feature length movies. The company sells and markets its products and services through a direct sales organization, independent agents, and distributors. SeaChange International, Inc. was founded in 1993 and is headquartered in Acton, Massachusetts.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SeaChange International (Nasdaq: SEAC ) , whose recent revenue and earnings are plotted below.
Hot Cheapest Stocks For 2014: Evercore Partners Inc(EVR)
Evercore Partners Inc. operates as an independent investment banking advisory firm. The company operates through two segments, Investment Banking and Investment Management. The Investment Banking segment offers advisory services on mergers, acquisitions, divestitures, and other strategic corporate transactions primarily for multinational corporations and private equity firms; and restructuring advice to companies in financial transition, as well as to creditors, shareholders, and potential acquirers. This segment also provides capital markets advice; underwrites securities offerings; raises funds for financial sponsors; and offers equity research and agency-only equity securities trading for institutional investors. The Investment Management segment manages financial assets for institutional investors; provides independent fiduciary services to corporate employee benefit plans; provides wealth management services for high net-worth individuals; manages private equity funds ; and offers specialized investment management and trustee services. The company operates primarily in the United States, Europe, and Latin America. Evercore Partners Inc. was founded in 1996 and is headquartered in New York, New York.
Advisors' Opinion:- [By Jonathan Levin]
The company began operations in 2006 and its fleet includes Airbus SAS single-aisle A319 and A320 jets. Owners include Indigo Partners LLC, Evercore Partners Inc. (EVR) and Evercore Co-Chairman Pedro Aspe, a former Mexico finance minister, according to the pre-IPO filing.
Hot Cheapest Stocks For 2014: NMI Holdings Inc (NMIHZ)
NMI Holdings, Inc. (NMIH), incorporated on May 19, 2011, is a development-stage company. The Company through its subsidiaries provides private mortgage insurance in the United States. The Company�� wholly owned subsidiaries include National Mortgage Insurance Corporation and National Mortgage Reinsurance Inc One.
On April 24, 2012, NMI Holdings, Inc. (NMI) closed an agreement with MAC Financial Ltd. to acquire MAC Financial Holdings Corporation and its wholly owned subsidiaries. On September 30, 2013, the Company merged MAC Financial Holding Corporation into NMIH, with NMIH surviving the merger, and it merged NMRI Two into NMIC, with NMIC surviving the merger.
Advisors' Opinion:- [By Zachary Tracer]
NMI Holdings Inc. (NMIHZ), a mortgage insurer backed by funds tied to Carlyle Group LP (CG) and Kyle Bass, filed to sell shares in an initial public offering as investors bet on a housing-market rebound.
Hot Cheapest Stocks For 2014: Callaway Golf Co (ELY)
Callaway Golf Company, incorporated on May 7, 1999, together with its subsidiaries, designs, manufactures and sells golf clubs (drivers, fairway woods, hybrids, irons, wedges and putters) and golf balls, and also sells golf accessories (such as golf bags, golf gloves, headwear, towels, umbrellas and travel gear) under the Callaway Golf and Odyssey brand names. The Company sells pre-owned golf products through its Website, www.callawaygolfpreowned.com. In addition, it sells Callaway Golf and Odyssey products direct to consumers online through its Websites shop.callawaygolf.com and www.odysseygolf.com. The Company also licenses its trademarks and service marks in exchange for a royalty fee to third parties for use on golf related accessories, including apparel, footwear, eyewear, rangefinders and practice aids. Its products are sold in the United States and in approximately 100 countries around the world.
The Company designs, manufactures and sells golf clubs and golf balls, and designs and sells golf accessories. The Company�� products are designed for golfers of all skill levels, both amateur and professional. The Company�� principal products include Drivers, Fairway Woods and Hybrids; Irons; Putters; Golf Balls, and Accessories, Softgoods and Other. Drivers, Fairway Woods and Hybrids product category includes sales of the Company�� drivers, fairway woods and hybrid products, which are sold under the Callaway Golf brand. Irons include sales of the Company�� irons and wedges, which are sold under the Callaway Golf brand. Putters include sales of the Company�� putters, which are sold under the Odyssey brand. Golf Balls includes sales of the Company�� golf balls, which are sold under the Callaway Golf and Strata brands. Accessories, Softgoods and Other includes sales of golf bags, golf gloves, golf footwear, rangefinders, golf apparel, packaged club sets, headwear, towels, umbrellas, eyewear and other accessories, as well as sales of pre-owned products through www.callawaygolfpre! owned.com. Additionally, this product category includes royalties from licensing of the Company�� trademarks and service marks on products such as golf apparel, golf footwear, rangefinders and practice aids.
The Company competes with TaylorMade, Ping, Acushnet, Puma, SRI Sports Limited, Mizuno, Bridgestone, and Nike.
Advisors' Opinion:- [By Jake L'Ecuyer]
Callaway Golf (NYSE: ELY) was down as well, dropping 9.70 percent to $7.54 after the Dick's Sporting goods earnings report unveiled a weakness in the golf market which traders applied to Callaway, using it as a catalyst to push the shares lower.
- [By Lauren Pollock]
Callaway Golf Co.'s(ELY) third-quarter loss narrowed significantly as the golf equipment maker reported a jump in sales and sharp increase in gross margins. Results for the period easily topped Wall Street’s expectations, sending shares up.
- [By Peter Graham]
The Q3 2014 earnings report for small cap golf stock Callaway Golf Co (NYSE: ELY), a potential peer of sporting goods or sporting equipment stocks like Toronto listed�Performance Sports Group Ltd (NYSE: PSG) and Johnson Outdoors Inc (NASDAQ: JOUT), is scheduled for after the market closes on Thursday (October 23rd). Aside from the Callaway Golf earnings report, it should be said that Performance Sports Group Ltd reported Q1 2015 on October 9th (revenues were up 28% to $197.1 million) while the estimated release date for the Q4 2014 Johnson Outdoors Inc earnings report is�October 31st. However, Callaway Golf is the last publicly traded�pure play golf equipment stock�giving investors direct exposure to the game���especially since Dicks Sporting Goods Inc (NYSE: DKS)�recently took a $20.4 million pretax golf restructuring charge and plans to focus more attention on other sports.
Hot Cheapest Stocks For 2014: Seattle Genetics Inc.(SGEN)
Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Its lead product, SGN-35 is in pivotal trial stage used for the treatment of patients with relapsed or refractory hodgkin lymphoma. The company?s other product candidates in various stages of clinical trials include SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; dacetuzumab (SGN-40), a humanized anti-CD40 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc .; Daiichi Sankyo Co., Ltd.; Genentech, Inc.; GlaxoSmithKline LLC; Millennium; and PSMA Development Company LLC. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc.; and Genmab A/S. Seattle Genetics, Inc. was founded in 1997 and is headquartered in Bothell, Washington.
Advisors' Opinion:- [By Henry Kawabe]
A number of analysts believe the stock of the biotech company Seattle Genetics (SGEN) has risen too high too quickly to support its current price, and have issued much lower target prices on the stocks than where it currently sits. On Thursday August 1st, Analysts at Cantor Fitzgerald issued a target price of $24 a share with a "sell" recommendation as they see the potential downside of the stock could drop 40.77% from its July 31st close. Previously, on June 10th, Zacks downgraded the stock and placed a price target of $41.20 per share. In May, analysts at UBS AG issued a price target from $30.00 to $36.00 giving the stock a "neutral" rating, while analysts at Leerink Swann issued a price target of $42.00. So far, the analysts have been wrong as Seattle Genetics has blown past their price targets, and as of August 2nd, the stock continued to rise, closing at $43.28 per share.
- [By Rich Bieglmeier]
[Related -Seattle Genetics, Inc. (SGEN), Takeda Report Encouraging Data From ADCETRIS Study]
Let's take a look at what $2 billion in ADCETRIS sales could mean for the stock price and where SGEN shares would need to trade to become a low-end large cap stock.
- [By Brian Orelli]
Seattle Genetics (NASDAQ: SGEN ) is up in after-hours trading after posting record sales for its blood cancer drug Adcetris, and raising guidance for the year. The biotech sold $48 million worth of Adcetris in the U.S. and Canada, a 32% year-over-year increase.
- [By Roberto Pedone]
One biotechnology player that insiders are snapping up a huge amount of stock in here is Seattle Genetics (SGEN), which develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. Insiders are buying this stock into huge strength, since shares are up sharply by 72% so far in 2013.
Seattle Genetics has a market cap of $4.9 billion and an enterprise value of $4.5 billion. This stock trades at a premium valuation, with a price-to-sales of 19.09 and a price-to-book of 21.65. Its estimated growth rate for this year is -37%, and for next year it's pegged at -6.3%. This is a cash-rich company, since the total cash position on its balance sheet is $373.85 million and its total debt is zero.
A director just bought 1,005,901 shares, or about $43.44 million worth of stock, at $42.31 to $43.98 per share.
From a technical perspective, SGEN is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock has been downtrending over the last few weeks, with shares dropping from its high of $45.37 to its intraday low of $39.85 a share. During that move, shares of SGEN have been consistently making lower highs and lower lows, which is bearish technical price action.
If you're bullish on SGEN, then I would look for long-biased trades as long as this stock is trending above its 200-day of $38.40 or above more near-term support at $36.79 and then once it takes out its 50-day at $41.02 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 856,995 shares. If we get that move soon, then SGEN will set up to re-test or possibly take out its next major overhead resistance levels at $45.37 $46.48 a share. Any high-volume move above those levels will then give SGEN a chance to tag its 52-week high at $49.23 a share.
No comments:
Post a Comment